This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Taylor, P. R.
Right arrow Articles by Botto, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Taylor, P. R.
Right arrow Articles by Botto, M.

 Previous Article  |  Next Article 

Infection and Immunity, June 2001, p. 3853-3859, Vol. 69, No. 6
0019-9567/01/$04.00+0   DOI: 10.1128/IAI.69.6.3853-3859.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.

Complement Contributes to Protective Immunity against Reinfection by Plasmodium chabaudi chabaudi Parasites

Philip R. Taylor,1,dagger Elsa Seixas,2,3 Mark J. Walport,1 Jean Langhorne,3 and Marina Botto1,*

Rheumatology Section, Division of Medicine, Imperial College School of Medicine, Hammersmith Campus, London W12 0NN,1 Department of Biology, Imperial College of Science, Technology and Medicine, London SW7 3AA,2 and Division of Parasitology, National Institute for Medical Research, The Ridgeway, Mill Hill, London NW7 1AA,3 United Kingdom

Received 27 December 2000/Returned for modification 20 February 2001/Accepted 15 March 2001

We have studied the impact of deficiency of the complement system on the progression and control of the erythrocyte stages of the malarial parasite Plasmodium chabaudi chabaudi. C1q-deficient mice and factor B- and C2-deficient mice, deficient in the classical complement pathway and in both the alternative and classical complement activation pathways, respectively, exhibited only a slight delay in the resolution of the acute phase of parasitemia. Complement-deficient mice showed a transiently elevated level of gamma interferon (IFN-gamma ) in the plasma at the time of the acute parasitemia compared with that of wild-type mice. Although there was a trend for increased precursor frequencies in CD4+ T cells from C1q-deficient mice producing IFN-gamma in response to malarial antigens in vitro, intracellular cytokine staining of spleen cells ex vivo showed no difference in the numbers of IFN-gamma + splenic CD4+ and CD8+ cells. In contrast, C1q-deficient animals were significantly more susceptible to a second challenge with the same parasite. C1q-deficient animals showed a reduced level of anti-malarial immunoglobulin G2a (IgG2a) antibody 100 days after primary infection. However, following a significantly higher parasitemia, C1q-deficient mice had increased levels of IgM and IgG2a anti-malarial antibodies. In summary, this study indicates that while complement plays only a minor role in the control of the acute phase of parasitemia of a primary infection, it does contribute to parasite control in reinfection.


* Corresponding author. Mailing address: Rheumatology Section, Division of Medicine, Imperial College School of Medicine, Hammersmith Campus, Du Cane Rd., London W12 0NN, United Kingdom. Phone: 44 (0) 20 8383 2316. Fax: 44 (0) 20 8743 3109. E-mail: m.botto{at}ic.ac.uk.

dagger Present address: Sir William Dunn School of Pathology, Oxford University, South Parks Rd., Oxford OX1 3RE, United Kingdom.


Infection and Immunity, June 2001, p. 3853-3859, Vol. 69, No. 6
0019-9567/01/$04.00+0   DOI: 10.1128/IAI.69.6.3853-3859.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.



This article has been cited by other articles:

  • Patel, S. N., Lu, Z., Ayi, K., Serghides, L., Gowda, D. C., Kain, K. C. (2007). Disruption of CD36 Impairs Cytokine Response to Plasmodium falciparum Glycosylphosphatidylinositol and Confers Susceptibility to Severe and Fatal Malaria In Vivo. J. Immunol. 178: 3954-3961 [Abstract] [Full Text]